Influenza treatment with oseltamivir outside of labeled recommendations

American Journal of Health-System Pharmacy

Volumn 72, Issue 2, 2015, Pages 112-116

  McQuade, Brianna ^a   Blair, Melissa ^a  

^a NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; VIRUS RNA;

ANTIVIRAL THERAPY; CRITICALLY ILL PATIENT; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DYSPNEA; HOSPITALIZATION; HUMAN; HYPOXIA; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LENGTH OF STAY; OFF LABEL DRUG USE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SURVIVAL; SYMPTOM; SYSTEMATIC REVIEW (TOPIC); TACHYPNEA; TREATMENT DURATION; VIRUS CONCENTRATION; VIRUS SHEDDING; VIRUS STRAIN; ANIMAL; DRUG EFFECTS; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; PROCEDURES; TREATMENT OUTCOME;

ANIMALS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OFF-LABEL USE; OSELTAMIVIR; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84930165637     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp140390     Document Type: Review

References (18)

1. Centers for Disease Control and Prevention. Estimating seasonal influenza-associated deaths in the United States: CDC study confirms variability of flu. www.cdc.gov/flu/about/disease/us-flu-related-deaths.htm (accessed 2014 Jan 20).
2. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm (accessed 2014 Nov 4).
3. Oseltamivir phosphate [monograph]. In: LexiComp Online [online database]. Hudson, OH: Lexi-Comp (accessed 2014 Jan 20).
4. Tamiflu (oseltamivir phosphate) package insert. San Francisco, CA: Genetech, Inc.; 2013 Jan.
5. Centers for Disease Control and Prevention. Influenza antiviral drug resistance. www.cdc.gov/flu/about/qa/antiviralresistance.htm (accessed 2014 Jan 20).
6. Jefferson T, Jones MA, Doshi P et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014; 4:CD008965.
7. Carrat F, Vergu E, Ferguson NM et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol. 2008; 167:775-85.
8. Aoki FY, Macleod MD, Paggiaro P et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother. 2003; 51:123-9.
9. Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48:1003-32.
10. Centers for Disease Control and Prevention. Use of antivirals. www.cdc.gov/flu/professionals/antivirals/antiviral-use-influenza.htm (accessed 2014 Aug 18).
11. Yu H, Feng Z, Uyeki T et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis. 2011; 52: 4:457-65.
12. Louie JK, Yang S, Acosta M et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1) pdm09. Clin Infect Dis. 2012; 55:1198-204.
13. Hsu J, Santesso N, Mustafa R et al. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med. 2012; 156:512-24.
14. McGeer A, Green KA, Plevneshi A et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007; 45:1568-75.
15. Lee N, Chan PK, Hui DS et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009; 200:492-500.
16. Nicholson KG, Aoki FY, Osterhaus AD et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomized controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000; 356:1845-50.
17. South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomized controlled trial. BMJ. 2013; 346:1-16.
18. Centers for Disease Control and Prevention. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). www.cdc.gov/mmwr/pdf/rr/rr6001.pdf (accessed 2014 Aug 18).